Clinical Trial

Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy

Study acronym: STARTER
Recruiting
View on ClinicalTrials.gov →
Summary
This study will include patients diagnosed with Arrhythmogenic cardiomyopathy (ACM) in the First Affiliated Hospital of Xi 'an Jiaotong University and other centers, and collect clinical data and biological samples of patients with different ACM phenotypes. Through the establishment of disease cohort and long-term follow-up, to explore the disease characteristics, development law, clinical characteristics, natural course of disease and long-term prognosis of ACM.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-02.
Status change: Not Yet Recruiting → Recruiting 2024-07-10
Trial Details
NCT Number NCT06352307
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Conditions Arrhythmogenic Cardiomyopathy
Enrollment 1,500 participants
Start Date 2024-04-09
Primary Completion 2030-08-31 (estimated)
Study Completion 2032-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-12